Canadian Medical Association Journal Home

Table of Contents
Free eCMAJ TOC

Back issues
Supplements
Selected series

eLetters
About this journal
Info for authors

PubMed

The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance
Maxime Lamarre-Cliche,† Jean Cusson†‡
CMAJ 2001;164(3):372-6 [PDF]


Abstract

The head-upright tilt-table (HUT) test is used primarily for the investigation of orthostatic symptoms. Although this test is frequently the gold standard for the evaluation of neurocardiogenic syncope, dysautonomia and postural orthostatic tachycardia syndrome, there is a debate over its diagnostic value and method. The authors review the physiologic basis of the HUT test, the method, patterns of response, indications and contraindications, and diagnostic validity. Despite its limitations, the HUT test is useful in patients with a variety of clinical manifestations induced by orthostatism. It is most useful in documenting objective measures of orthostatic hypertension that cannot be obtained in a clinical setting.


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Syncope, fainting, dizziness, weakness and palpitations occurring in the upright position are not uncommon complaints and are associated with a variety of disorders (Table 1). New tools and concepts have been developed, resulting in the emergence of new diagnoses, such as postural orthostatic tachycardia syndrome (POTS)1 and neurocardiogenic syncope,2 and new scales, such as the composite autonomic scoring scale3 and orthostatic intolerance grading by symptoms.4 Modern technology has allowed us to improve sensitivity in detecting dysautonomia. The head-upright tilt-table (HUT) test, over half a century old, has retained a central place in the investigation of syncope of unknown origin,5,6,7,8,9,10 orthostatic intolerance and dysautonomia.11,12 However, the test is of debatable value and has been the subject of many articles in the past 10 years. We review the physiologic basis of the HUT test, the method, patterns of response, indications and contraindications, and diagnostic validity.
Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Physiologic basis

On standing, about 300 to 800 mL of blood is forced downward to the abdominal area and lower extremities.8,12 Within seconds of this sudden decrease in venous return, pressure receptors in the heart, lungs, carotid sinus and aortic arch are activated and mediate an increase in sympathetic outflow. Through vasoconstriction of capacitance and arteriolar vessels and through increased heart output, a healthy subject is able to reach orthostatic stabilization in 60 seconds or less. This neurally mediated mechanism is the only one by which we can adapt to the first few minutes of an upright position, and it remains the most important afterward. Orthostatic stress and sympathetic activity have been shown to increase with the angle of HUT testing.13,14,15,16,17 Hemodynamic and hormonal data suggest that this stress is exerted mostly between 60° and 90°.6,16


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Method

Tilt-table testing examines the neurocardiovascular orthostatic response in a maximally controlled environment. With passive orthostasis, stress is maximized on the sympathetic system by blocking the influence of inferior limb musculoskeletal contractions that could increase venous return. The table angle, duration of tilting and addition of pharmacologic stimulation are all under the examiner's control. The HUT test is a dedicated test in which the orthostatic challenge is much longer than can be allowed in an office setting, the controlled variables of the test maximize its value, and the partly automated setup enables the physician to pay more attention to the patient's symptoms.

Tilt-table testing has 2 main phases. It begins with supine resting for at least 30 minutes. This phase has great importance because it allows stabilization of the cardiovascular system and may increase the sensitivity of the test.18 In the second phase the patient is tilted upright for 30 to 45 minutes, usually at an angle of 60° to 80°. At this angle near-maximal passive orthostatic stress6,16 is exerted. A third phase, in which the test is repeated with pharmacologic stimulation, is sometimes used in the investigation of unexplained syncope. Isoproterenol is the most common provocative agent; edrophonium, nitroglycerine, adenosine triphosphate, epinephrine and nitroprusside6 have also been used. During the entire procedure the blood pressure and heart rate are measured regularly with an automated device, at least every 3 minutes while the patient is tilted.


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Induced hemodynamic patterns

Four patterns can be identified during HUT testing (Fig. 1). The normal response consists of an increase in heart rate of approximately 10 to 15 beats/min, an elevation of diastolic pressure of about 10 mm Hg and little change in systolic pressure12 (Fig. 1A). Abnormal responses are POTS and orthostatic hypotension. The POTS pattern (Fig. 1B) consists of a sustained increase in heart rate of at least 30 beats/min4 or a sustained pulse rate of 120 beats/min.19 Orthostatic hypotension is defined as a reduction in systolic blood pressure of at least 20 mm Hg or a reduction in diastolic blood pressure of at least 10 mm Hg.20 Neurocardiogenic syncope (Fig. 1C) usually appears as a symptomatic and sudden drop in blood pressure, often after 10 minutes or more of HUT testing and frequently with simultaneous bradycardia.5 An immediate and continuing drop in systolic and diastolic pressure without a significant increase in heart rate signals the presence of dysautonomia (Fig. 1D). A psychogenic reaction relates to symptoms unrelated to changes in heart rate or blood pressure.

Approaches to medical management will clearly be different depending on the response. The dysautonomic patient needs further investigation (e.g., for diabetes mellitus and extrapyramidal disorders), attention being given to attenuating venous pooling in the lower limbs and perhaps raising the blood pressure with drugs.21 The patient with neurocardiogenic syncope or POTS may also benefit from ß-blockade, if not contraindicated.2,4


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Indications

HUT testing can be part of the investigation of any orthostatic symptom, especially in patients with no objective physical findings and no evidence of structural cardiovascular disease. Usually, it is part of the diagnostic algorithm of syncope or presyncope.6,9 The indications recommended by the American College of Cardiology6 are given in Table 2.


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Contraindications and adverse effects

Contraindications to HUT testing are unstable cardiovascular disease, pregnancy and patient refusal. Many laboratories recommend that men older than 45 years and women older than 55 years undergo stress testing before tilt-table testing and that women of childbearing age have a pregnancy test.8

HUT testing is generally safe, but there have been occasional reports of coronary vasospasm,22 chest pain,5 hypertensive crisis5 and tachyarrhythmia.5,6 The most frequent adverse effects are hemodynamic changes, such as hypotension, tachycardia or bradycardia associated with orthostatic intolerance, presyncope or syncope. It is noteworthy that patients with neurocardiogenic syncope may rarely experience asystole (defined as ventricular pause of more than 5 seconds) or complete atrioventricular block during HUT testing. Lacroix and colleagues23 reported 10 asystolic reactions (6%) (average duration 12 seconds) among 179 patients investigated for neurocardiogenic syncope; 8 patients needed cardiopulmonary resuscitation for 20 to 30 seconds. Dhala and associates24 reported 19 asystolic reactions (9%) among 209 patients with suspected neurocardiogenic syncope and 3 asystolic responses (4%) among 75 healthy control subjects during HUT testing without pharmacologic stimulation. These subjects did not show a worse outcome than their nonasystolic counterparts during follow-up.24,25


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Performance

We performed a MEDLINE search to identify studies of the reproducibility, sensitivity and specificity of HUT testing in adults using "orthostatic hypotension," "neurally mediated syncope" and "syncope" as key words. Articles providing details about the HUT test and patient selection were included. We found many studies on the topic, but study methods and populations were quite heterogeneous.


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Reproducibility

Reproducibility is an important characteristic of a diagnostic tool. From studies in which data on HUT testing were obtained on at least 2 occasions, with a known time interval,23,26,27,28,29,30,31,32,33,34,35 we calculated an average reproducibility of 81%. However, as Behzad and collaborators27 and other authors23,28 have highlighted, negative results are much more reproducible than positive ones (about 95% and 50% respectively). The reproducibility of HUT testing depends strongly on population selection as it is increased in patients with severe and frequent orthostatic symptoms. Clustering of orthostatic symptoms in time also heavily impairs the reproducibility of any 2 diagnostic tests significantly apart in time.


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Diagnostic validity

Age, severity of symptoms, type of symptoms, proportion of subjects with dysautonomia and selection of subjects can influence pretest disease prevalence. The lack of a gold standard for assessing the value of the HUT test is an important limitation; patients with dysautonomia are frequently identified by positive results of HUT testing.

Studies attempting to assess the validity of the HUT test as a diagnostic test have used a combination of questionnaire, physical examination and paraclinical tests (excluding HUT testing) as the gold standard for comparison purposes. Not surprisingly, estimates of sensitivity (number of subjects with positive findings on HUT testing divided by the total number of symptomatic subjects tested) are quite variable.

Studies assessing the ability of the HUT test to diagnose neurocardiogenic syncope averaged a sensitivity of 35% without pharmacologic stimulation and 57% with pharmacologic stimultion.25,27-33,36,37,38,39,40,41,42,43,44,45,46,47,48,49, 50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65 Studies using HUT testing within the boundaries set by the American College of Cardiology guidelines6 averaged a sensitivity of 65%.31,38,48,53,58 It is noteworthy that the yield is not increased by repeating the test.27

The specificity (number of subjects with negative results divided by the number of healthy subjects tested) of the HUT test for neurocardiogenic syncope was 92% on average without pharmacologic stimulation32,34,37,50-58,60-65,66,67,68,69,70,71 and 81% with pharmacologic stimulation.50,51,53,55-58,61,63,67,69 Two investigations in which HUT testing was used within the boundaries set by the American College of Cardiology guidelines6 both yielded a specificity of 100%.53,58

Several investigations have established that abnormal results of tilt-table testing correlate with autonomic nervous system diseases72,73,74,75,76 and other tests of autonomic function.72,74,75,76 Axelrod and coworkers77 tilted 10 patients with familial dysautonomia at an angle of 90° for 5 minutes and had positive results in all cases. Ward and Kenny78 reported that 14 of 19 dysautonomic patients (74%) had orthostatic hypotension with a 70° tilt for 5 minutes. In the study by Khurana and Nicholas65 73% of 39 dysautonomic subjects were correctly identified within 5 minutes at a 90° tilt. Grubb and colleagues79 identified patients with orthostatic intolerance and orthostatic tachycardia without full syncope (POTS) and studied HUT testing prospectively. A 45-minute 80° tilt resulted in a sensitivity of 100%.


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

Conclusion

Despite its limitations, the HUT test is useful in patients with a variety of clinical manifestations induced by orthostatism. It is most useful in documenting objective measures of orthostatic hypotension that cannot be obtained in a clinical setting.

Patients considered for HUT testing must be carefully selected to enhance diagnostic value. Abnormal hemodynamic response to the test in patients with clear clinical orthostatic symptoms is strong evidence for disease and should prompt changes in medical management, such as modification of lifestyle, use of compressive stockings or initiation of drug therapy.

Evaluation of treatment efficacy by serial HUT testing is still of unproven value. Despite the wide variability in orthostasis-related symptoms, the best indicator of treatment failure or success remains global evaluation of the symptoms experienced by the patient.

Competing interests: None declared.

Contributors: Dr. Lamarre-Cliche was primarily responsible for collecting and analyzing the data and for developing the manuscript. Dr. Cusson conceived the research questions and contributed to data analyses and development of the manuscript.

Acknowledgments: We thank Mr. Ovid Da Silva, of the Bureau d'aide à la recherche, Centre hospitalier de l'Université de Montréal, for his editorial work and Mrs. Louise Murray for preparing the manuscript.


Contents
• Abstract • Introduction • Physiologic basis • Method • Induced hemodynamic patterns • Indications • Contraindications and adverse effects • Performance • Reproducibility • Diagnostic validity • Conclusion • References

From the *Centre hospitalier de l'Université de Montréal, the †Service de médecine interne and the ‡Département de pharmacologie, Université de Montréal, Montreal, Que.

This article has been peer reviewed.

Reprint requests to: Dr. Jean Cusson, Hôpital Charles LeMoyne, 3120, boul. Taschereau, Greenfield Park QC J4V 2H1; fax 450 466-5606; jean_cusson@hotmail.com


References

    1.   Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia? Neurology 1993;43:132-7. [MEDLINE]
    2.   Kaufmann H. Neurally mediated syncope: pathogenesis, diagnosis, and treatment. Neurology 1995;45(suppl 5):S12-8. [MEDLINE]
    3.   Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748-52. [MEDLINE]
    4.   Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, et al. Postural tachycardia syndrome (POTS). Neurology 1995;45(suppl 5):S19-25. [MEDLINE]
    5.   Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994;97:78-88. [MEDLINE]
    6.   Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, et al. Tilt table testing for assessing syncope. J Am Coll Cardiol 1996;28(1):263-75. [MEDLINE]
    7.   Kapoor WN. Using a tilt table to evaluate syncope. Am J Med Sci 1999;317(2):110-6. [MEDLINE]
    8.   Grubb BP, Kimmel S. Head-upright tilt table testing. A safe and easy way to assess neurocardiogenic syncope. Postgrad Med 1998;103(1):133-40. [MEDLINE]
    9.   Linzer M, Yang EH, Estes NAM, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Ann Intern Med 1997;126(12):989-96. [MEDLINE]
    10.   Grubb BP, Kosinski D. Current trends in etiology, diagnosis, and management of neurocardiogenic syncope. Curr Opin Cardiol 1996;11:32-41. [MEDLINE]
    11.   Taylor AA. Autonomic control of cardiovascular function: clinical evaluation in health and disease. J Clin Pharmacol 1994;34:363-74. [MEDLINE]
    12.   Grubb B, Kosinski D. Dysautonomic and reflex syncope syndromes. Cardiol Clin 1997;15(2):257-68. [MEDLINE]
    13.   Montano N, Gnecchi Ruscone T, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994;90:1826-31. [MEDLINE]
    14.   de Mey C, Enterling D. Assessment of the hemodynamic response to single passive head up tilt by non-invasive methods in normotensive subjects. Methods Find Exp Clin Pharmacol 1986;8(7):449-57. [MEDLINE]
    15.   Smith JJ, Hughes CV, Ptacin MJ, Barney JA, Tristani FE, Ebert T. The effect of age on hemodynamic response to graded postural stress in normal men. J Gerontol 1987;42(4):406-11. [MEDLINE]
    16.   Segel N, Dougherty R, Sackner MA. Effects of tilting on pulmonary capillary blood flow in normal man. J Appl Physiol 1973;35(2):244-9. [MEDLINE]
    17.   Stevens PM. Cardiovascular dynamics during orthostasis and the influence of intravascular instrumentation. Am J Cardiol 1966;17:211-8. [MEDLINE]
    18.   Ten Harkel ADJ, Van Lieshout JJ, Van Lieshout EJ, Wieling W. Assessment of cardiovascular reflexes: influence of posture and period of preceding rest. J Appl Physiol 1990;68:147-53. [MEDLINE]
    19.   Novak V, Spies JM, Novak P, McPhee BR, Rummans TA, Low PA. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke 1998;29:1876-81. [MEDLINE]
    20.   Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996;46:1470. [MEDLINE]
    21.   Schatz IJ. Orthostatic hypotension. II. Clinical diagnosis, testing, and treatment. Arch Intern Med 1984;144(5):1037-41. [MEDLINE]
    22.   Wang CH, Lee CC, Cherng WJ. Coronary vasospasm induced during isoproterenol head-up tilt test. Am J Cardiol 1997;80:1508-10. [MEDLINE]
    23.   Lacroix D, Kouakam C, Klug D, Guedon-Moreau L, Vaksmann G, Kacet S, et al. Asystolic cardiac arrest during head-up tilt test: incidence and therapeutic implications. Pacing Clin Electrophysiol 1997;20:2746-54. [MEDLINE]
    24.   Dhala A, Natale A, Sra J, Deshpande S, Blanck Z, Jazayeri MR, et al. Relevance of asystole during head-up tilt testing. Am J Cardiol 1995;75:251-4. [MEDLINE]
    25.   Folino AF, Buja GF, Martini B, Miorelli M, Nava A. Prolonged cardiac arrest and complete AV block during upright tilt test in young patients with syncope of unknown origin — prognostic and therapeutic implications. Eur Heart J 1992;13:1416-21. [MEDLINE]
    26.   Morillo CA, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22(7):1843-8. [MEDLINE]
    27.   Behzad B, Pavri BB, Ruskin JN, Brooks R. The yield of head-up tilt testing is not significantly increased by repeating the baseline test. Clin Cardiol 1996;19:494-6. [MEDLINE]
    28.   Chen XC, Chen MY, Remole S, Kobayashi Y, Dunnigan A, Milstein S, et al. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol 1992;69:755-60. [MEDLINE]
    29.   Sheldon R, Splawinski J, Killam S. Reproducibility of isoproterenol tilt-table tests in patients with syncope. Am J Cardiol 1992;69:1300-5. [MEDLINE]
    30.   Kou WH, Randall DK, Dorset DN, Koch KS. Immediate reproducibility of tilt-table test results in elderly patients referred for evaluation of syncope or presyncope. Am J Cardiol 1997;80:1492-4. [MEDLINE]
    31.   Grubb BP, Wolfe D, Temesy-Armos P, Hahn H, Elliott L. Reproducibility of head-upright tilt-table test. Results in patients with syncope. Pacing Clin Electrophysiol 1992;15:1477-81. [MEDLINE]
    32.   Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17:125-30. [MEDLINE]
    33.   Morillo CA, Klein GJ, Zandri S, Yee R. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995;129:901-6. [MEDLINE]
    34.   Patel A, Maloney A, Damato AN. On the frequency and reproducibility of orthostatic blood pressure changes in healthy community-dwelling elderly during 60-degree head-up tilt. Am Heart J 1993;126:184-8. [MEDLINE]
    35.   Blanc JJ, Mansourati J, Maheu B, Boughaleb D, Genet L. Reproducibility of a positive passive upright tilt test at a seven-day interval in patients with syncope. Am J Cardiol 1993;72:469-71. [MEDLINE]
    36.   Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989;1:658-60. [MEDLINE]
    37.   McIntosh SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head-up tilt testing for vasovagal syncope in elderly patients. Age Ageing 1994;23:317-9. [MEDLINE]
    38.   Grubb BP, Gerard G, Roush K, Temesy-Armos P, Montford P, Elliott L, et al. Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. A paradoxic and unexpected response. Circulation 1991;84:1157-64. [MEDLINE]
    39.   Sheldon R, Killam S. Methodology of isoproterenol tilt-table testing in patients with syncope. J Am Coll Cardiol 1992;19:773-9. [MEDLINE]
    40.   Calkins H, Kadish A, Sousa J, Rosenheck S, Morady F. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Cardiol 1991;67:207-9. [MEDLINE]
    41.   Sra JS, Anderson AJ, Sheikh SH, Avitall B, Tchou PJ, Troup PJ, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med 1991;114:1013-9. [MEDLINE]
    42.   Voice RA, Lurie KG, Sakaguchi S, Rector TS, Benditt DG. Comparison of tilt angles and provocative agents (edrophonium and isoproterenol) to improve head-upright tilt-table testing. Am J Cardiol 1998;81:346-51. [MEDLINE]
    43.   Chen MY, Goldenberg IF, Milstein S, Buetikofer J, Almquist A, Lesser J, et al. Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope. Am J Cardiol 1989;63:66-72. [MEDLINE]
    44.   Brauninger S, Maas A, Nanke C, Stellwaag M, Uebis S, Lambertz H. [Tilt-table study in vasovagal syncope. The diagnostic gain from isoprenaline administration.] Dtsch Med Wochenschr 1996;121:971-7. [MEDLINE]
    45.   Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle LW. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. Pacing Clin Electrophysiol 1988;11:1202-14. [MEDLINE]
    46.   Van de Walle JP, Panagides D, Messier M, Iovescu D, Fourcade L, Bory M, et al. Tilt table testing of young adult patients: improved speed and sensitivity using an isoproterenol bolus and a continuous 60 degrees tilt. Pacing Clin Electrophysiol 1998;21:494-8. [MEDLINE]
    47.   Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993;71:1289-92. [MEDLINE]
    48.   Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliot L. Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol 1992;69:904-8. [MEDLINE]
    49.   Ruiz GA, Scaglione J, Gonzalez-Zuelgaray J. Reproducibility of head-up tilt test in patients with syncope. Clin Cardiol 1996;19:215-20. [MEDLINE]
    50.   Raviele A, Gasparini G, Di Pede F, Menozzi C, Brignole M, Dinelli M, et al. Nitroglycerine infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 1994;127:103-11. [MEDLINE]
    51.   Lurie KG, Dutton J, Mangat R, Newman D, Eisenberg S, Scheinman M. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing. Am J Cardiol 1993;72:1286-90. [MEDLINE]
    52.   Strasberg B, Rechavia E, Sagie A, Kusniec J, Mager A, Sclarovsky S, et al. The head-up tilt-table test in patients with syncope of unknown origin. Am Heart J 1989;118:923-7. [MEDLINE]
    53.   Grubb BP, Wolfe D, Samoil D, Madu E, Temesy-Armos P, Hahn H, et al. Recurrent unexplained syncope in the elderly: the use of head-upright tilt-table testing in evaluation and management. J Am Geriatr Soc 1992;40:1123-8. [MEDLINE]
    54.   Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986;1:1352-5. [MEDLINE]
    55.   Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 1992;116:358-63. [MEDLINE]
    56.   Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995;76:267-72. [MEDLINE]
    57.   Almquist A, Goldengerg IF, Milstein S, Chen MY, Chen X, Hansen R, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-51. [MEDLINE]
    58.   Grubb BP, Temesy-Armos P, Hahn H, Elliott L. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. Am J Med 1991;90:6-10. [MEDLINE]
    59.   Waxman MB, Yao L, Cameron DA, Wald RW, Roseman J. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 1989;63:58-65. [MEDLINE]
    60.   Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 1991;68:1032-6. [MEDLINE]
    61.   Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J 1991;122:1644-51. [MEDLINE]
    62.   Hackel A, Linzer M, Anderson N, Williams R. Cardiovascular and catecholamine responses to head-up tilt in the diagnosis of recurrent unexplained syncope in elderly patients. J Am Geriatr Soc 1991;39:663-9. [MEDLINE]
    63.   Aerts A, Dendale P, Strobel G, Block P. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope. Am Heart J 1997;133:504-7. [MEDLINE]
    64.   Raviele A, Gasparini G, Di Pede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990;65:1322-7. [MEDLINE]
    65.   Khurana RK, Nicholas EM. Head-up tilt table test: How far and how long? Clin Auton Res 1996;6:335-41. [MEDLINE]
    66.   Lye M, Walley T. Haemodynamic responses in young and elderly, healthy subjects during ambient and warm head-up tilt. Clin Sci 1998;94:493-8. [MEDLINE]
    67.   Natale A, Akhtar M, Jazayeri M, Dhala A, Blanck Z, Deshpande S, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995;92:54-8. [MEDLINE]
    68.   Lipsitz LA, Marks ER, Koestner J, Jonsson PV, Wei JY. Reduced susceptibility to syncope during postural tilt in old age. Arch Intern Med 1989;149:2709-12. [MEDLINE]
    69.   Radrigan F, Dumas E, Chamorro G, Casanegra P, Jalil J. Head-up tilt test in healthy asymptomatic patients. Rev Med Chil 1996;124:1187-91. [MEDLINE]
    70.   Jansen RWM, Lenders JWM, Thien T, Hoefnagels WHL. The influence of age and blood pressure on the hemodynamic and humoral response to head-up tilt. J Am Geriatr Soc 1989;37:528-32. [MEDLINE]
    71.   Shvartz E. Reliability of quantitative tilt table data. Aerosp Med 1968;39:1094-7. [MEDLINE]
    72.   Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C. Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson's disease and multiple system atrophy. J Hypertens 1998;16:1433-41. [MEDLINE]
    73.   Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 1997;7:321-6. [MEDLINE]
    74.   Plaschke M, Schwarz J, Dahlheim H, Backmund H, Trenkwalder C. Cardiovascular and renin responses to head-up tilt tests in parkinsonism. Acta Neurol Scand 1997;96:206-10. [MEDLINE]
    75.   Khurana RK, Setty A. The value of the isometric hand-grip test C studies in various autonomic disorders. Clin Auton Res 1996;6:211-8. [MEDLINE]
    76.   Mukkamala R, Mathias JM, Mullen TJ, Cohen RJ, Freeman R. System identification of closed-loop cardiovascular control mechanisms: diabetic autonomic neuropathy. Am J Physiol 1999;276:R905-12. [MEDLINE]
    77.   Axelrod FB, Putman D, Berlin D, Rutkowski M. Electrocardiographic measures and heart rate variability in patients with familial dysautonomia. Cardiology 1997;88:133-40. [MEDLINE]
    78.   Ward C, Kenny RA. Reproducibility of orthostatic hypotension in symptomatic elderly. Am J Med 1996;100:418-22. [MEDLINE]
    79.   Grubb BP, Kosinski DJ, Boehm K, Kip K. The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt-table testing. Pacing Clin Electrophysiol 1997;20(pt 1):2205-12. [MEDLINE]

 

 

Copyright 2001 Canadian Medical Association or its licensors